Prospects and challenges of building a cancer vaccine targeting telomerase
- 31 January 2008
- Vol. 90 (1) , 173-180
- https://doi.org/10.1016/j.biochi.2007.07.005
Abstract
No abstract availableKeywords
This publication has 87 references indexed in Scilit:
- A novel peptide–nucleotide dual vaccine of human telomerase reverse transcriptase induces a potent cytotoxic T-cell response in vivoBiochemical and Biophysical Research Communications, 2007
- Telomerase immunity from bench to bedside: round oneJournal of Translational Medicine, 2007
- In vitro anti-tumor immune response induced by dendritic cells transfected with hTERT recombinant adenovirusBiochemical and Biophysical Research Communications, 2006
- Telomerase peptide vaccination of patients with non-resectable pancreatic cancer: a dose escalating phase I/II studyBritish Journal of Cancer, 2006
- Identification of an immunogenic CD8+ T-cell epitope derived from γ-globin, a putative tumor-associated antigen for juvenile myelomonocytic leukemiaBlood, 2006
- A listing of human tumor antigens recognized by T cells: March 2004 updateCancer Immunology, Immunotherapy, 2004
- The promise of cancer vaccinesNature Reviews Cancer, 2004
- The Three Es of Cancer ImmunoeditingAnnual Review of Immunology, 2004
- Specific Association of Human Telomerase Activity with Immortal Cells and CancerScience, 1994
- Telomeres shorten during ageing of human fibroblastsNature, 1990